000 | 01447 a2200433 4500 | ||
---|---|---|---|
005 | 20250515140102.0 | ||
264 | 0 | _c20090107 | |
008 | 200901s 0 0 eng d | ||
022 | _a1096-8652 | ||
024 | 7 |
_a10.1002/ajh.21280 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWeinreb, Neal | |
245 | 0 | 0 |
_aA benchmark analysis of the achievement of therapeutic goals for type 1 Gaucher disease patients treated with imiglucerase. _h[electronic resource] |
260 |
_bAmerican journal of hematology _cDec 2008 |
||
300 |
_a890-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGaucher Disease _xdrug therapy |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aGlucosylceramidase _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aTaylor, John | |
700 | 1 | _aCox, Timothy | |
700 | 1 | _aYee, John | |
700 | 1 | _avom Dahl, Stephan | |
773 | 0 |
_tAmerican journal of hematology _gvol. 83 _gno. 12 _gp. 890-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.21280 _zAvailable from publisher's website |
999 |
_c18286108 _d18286108 |